Qingdao Vland Biotech Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Qingdao Vland Biotech Inc

Watchlist Manager

Watchlist

Price: 13.71 CNY -2.35% Market Closed

Market Cap: ¥3.5B

	Qingdao Vland Biotech Inc SSE:603739	CN
R	Rohas Tecnic Bhd KLSE:ROHAS	MY
	Gudang Garam Tbk PT IDX:GGRM	ID
N	NetApp Inc LSE:0K6F	US
	Asia Pacific Fibers Tbk PT IDX:POLY	ID
	Mega Manunggal Property Tbk PT IDX:MMLP	ID
C	Comvex SA XBSE:CMVX	RO
	FocalTech Systems Co Ltd TWSE:3545	TW
G	Greggs PLC F:41G1	UK
	Midland Exploration Inc OTC:MIDLF	CA
	Peruvian Metals Corp XTSX:PER	CA
	Yamato Holdings Co Ltd OTC:YATRY	JP
W	WHA Premium Growth Freehold and Leasehold Real Estate Investment Trust SET:WHART	TH

Profitability Summary

Qingdao Vland Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

43%

Sustainable 3Y Average Gross Margin

45%

Declining Gross Margin

44% > 43%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

9% > 9%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 6%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.